Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis

References

• Ahmad I, Sarkar AK, Bachhawat BK. Design of liposomes to improve delivery of amphotericin B in the treatment of aspergillosis. Mol Cell Biochem 1989; 91: 85–90
   PubMed Web of Science ®Google Scholar
• Ain Q, Sharma S, Khuller GK, Garg SK. Alginate-based oral drug delivery system for tuberculosis: Pharmacokinetics and therapeutic effects. J Antimicrob Chemother 2003; 51: 931–938
   PubMed Web of Science ®Google Scholar
• Alving CR, Edgar A, Steck WL, Chapman, Jr, Waits VB, Hendricks LD, Swartz GM, Jr, Hanson WL. Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci 1980; 26: 2231–2258
   PubMed Web of Science ®Google Scholar
• Banerjee G, Bhaduri AN, Basu M. Mannose-coated liposomal hamycin in the treatment of experimental leishmaniasis in hamsters. Biochem Med Metab Biol 1994; 53: 1–7
   PubMedGoogle Scholar
• Banerjee G, Nandi G, Mahato SB, Pakrashi A, Basu MK. Drug delivery system: Targeting of pentamidines to specific sites using sugar-grafted liposomes. J Antimicrob Chemother 1996; 38: 145–150
   PubMed Web of Science ®Google Scholar
• Basu N, Sett R, Das PK. Down-regulation of mannose receptors on macrophages after infection with leishmania donovani. Biochem J 1991; 277: 451–456
   PubMed Web of Science ®Google Scholar
• Black CDV, Walsen GJ, Ward RG. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans R Soc Trop Med Hyg 1977; 71: 550–552
   PubMed Web of Science ®Google Scholar
• Campos-Ponce M, Ponce C, Ponce E, Maingon RD. Leishmania chagasi/infantum: Further investigations on Leishmania tropisms in atyp cutaneous and visceral leishmaniasis foci in Central America. Exp Parasitol 2005; 109: 209–219
   PubMed Web of Science ®Google Scholar
• Chatterjee T, Gupta M. Antiprotozoal activity of the new antibiotic (MT81) against Leishmania donovani promastigotes in vitro. Indian Drugs 1991; 28: 224–227
   Google Scholar
• Das N, Mahato SB, Naskar K, Ghosh DK, Basu MK. Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis. Biochem Med Metab Biol 1990; 43: 133–139
   PubMedGoogle Scholar
• Davidson RN, Di Martino L, Gradoni L, Giacchino R, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis. Q J Med 1994; 87: 75–81
   PubMedGoogle Scholar
• Ghosh P, Bacchawat BK. Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I labeled gamma-globulin encapsulated in liposomes. Biochim Biophys Acta 1980; 632: 562–572
   PubMed Web of Science ®Google Scholar
• Ghosh P, Bachhawat BK, Surolia A. Synthetic glycolipids: Interaction with galactose-binding lectin and hepatic cells. Arch Biochem Biophys 1981; 206: 454–458
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Perry CM. Amphotericin B lipid complex: In visceral leishmaniasis. Drugs 2004; 64: 1905–1911
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Ryman BE. Lysosomal localization of β-fructofuranosidase containing liposomes injected into rats. Biochem J 1972; 129: 123–133
   PubMed Web of Science ®Google Scholar
• Guilbault GG. Handbook of enzymatic methods of analysis. Marcel Dekker Inc., New York 1976; Vol. 4: 123
   Google Scholar
• Gupta M, Chatterjee T, Sengupta S, Mazumdar SK. Structure of a new mycotoxin (MT81). Indian J Chem 1984; 23B: 393–394
   Google Scholar
• Gur E. Staining: Animal tissues Practical and Theoretical. Leonard Hill, London, UK 1962; 1
   Google Scholar
• Hartsel S, Boland J. Amphotericin B: New life for an old drug. Trends Pharmacol Sci 1996; 17: 445–449
   PubMed Web of Science ®Google Scholar
• Kafetzis DA, Velissariou IM, Stabouli S, Mavrikou M, Delis D, Liapi G. Treatment of paediatric visceral leishmaniasis: Amphotericin B or pentavalent antimony compounds?. Int J Antimicrob Agents 2005; 25: 26–30
   PubMed Web of Science ®Google Scholar
• Linhardt K, Waltzer K. Methods of enzyme analysis, H.U. Verlag Chemie Bergmeyer, GMBH Weinheim/Berstr. Academic Press, New York, London 1963; 783
   Google Scholar
• Medda S, Mukherjee S, Das N, Naskar K, Mahato SB, Basu MK. Sugar coated liposomes: A novel delivery system for increased drug efficacy and reduced drug toxicity. Biotechnol Appl Biochem 1993; 17: 37–47
   PubMed Web of Science ®Google Scholar
• Medda S, Mukhopadhyay S, Basu MK. Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J Antimicrob Chemother 1999; 44: 791–794
   PubMed Web of Science ®Google Scholar
• New RRC, Chance ML, Thomas SC, Peters W. Antileishmanial activity of a antimonials entrapped in liposomes. Nature 1978; 272: 55–56
   PubMed Web of Science ®Google Scholar
• Racker E. Preparation of coupling factor 6 (F6). Method Enzymol 1979; 55: 398–399
   PubMedGoogle Scholar
• Rees PH, Kager PA, Ogada T, Eeflinck Schattenkerk JK. The treatment of Kala-azar: A review with comments drawn from experience in Kenya. Trop Geogr Med 1985; 37: 37–46
   PubMedGoogle Scholar
• Rocheleau H, Saint-Germain G, Barwicz J, Gruda I, Therien HM. Modulation of amphotericin B activity by association with mannose ester. Immunopharmacol Immunotoxicol 1994; 16: 419–436
   PubMed Web of Science ®Google Scholar
• Sinha J, Mukhopadhyay S, Das N, Basu M. Targeting of liposomal Andrographolide to L.donovani -infected macrophages in vivo. Drug Deliv 2000; 7: 209–213
   PubMed Web of Science ®Google Scholar
• Stauber LA, Franchino E, Gurn J. An Eighty day method for screening compounds against Leishmania donovani in golden hamster. J Protozool 1958; 5: 269–273
   Google Scholar
• Surolia A, Bachhawat BK. The effect of lipid composition on liposome-lectin interaction. Biochem Biophys Res Commun 1978; 83: 779–782
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Goldmacher VS, Smirnov VN. Comparative studies on covalent and non-covalent immobilization of protein molecules on the surface of liposomes. Biochem Biophys Res Commun 1978; 85: 983–990
   PubMed Web of Science ®Google Scholar
• Tsagozis P, Karagouni E, Dotsika E. Function of CD8(+) T lymphocytes in a self-curing mouse model of visceral leishmani. Parasitol Int 2005; 54: 139–146
   PubMed Web of Science ®Google Scholar
• UNDP / World Bank / WHO. Antimonials: Large scale failure of leishmaniasis ‘alarming’. TDR News No. 34, UNDP/ World Bank/ WHO special programmes for research and Training in tropical diseases. Geneva 1990
   Google Scholar
• Utz JP, Bennet JE, Brandis MW, Butler WT, Hill GJ. Amphotericin B toxicity combined clinical staff conference at National Institute of Health. Ann Int Med 1964; 61: 334–354
   Web of Science ®Google Scholar